---
figid: PMC3876281__nihms-549624-f0001
figlink: /pmc/articles/PMC3876281/figure/F1/
number: F1
caption: In drug-sensitive cancers (left), the mutant oncogene exerts unilateral control
  over RAS, MEK/ERK, and PI3K/AKT pathway signaling. When inhibited by the appropriate
  TKI, these pathways are suppressed, resulting in cell cycle arrest and apoptosis.
  In drug-resistant cancers with a bypass track (right), the secondary RTK reactivates
  the signaling of at least one of the key downstream pathways, whereas the primary
  oncogene remains inhibited. Sustained activation of these pathways leads to continued
  cell proliferation and survival in the presence of TKI.
pmcid: PMC3876281
papertitle: Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition
  in Lung Cancer.
reftext: Matthew J. Niederst, et al. Sci Signal. ;6(294):10.1126/scisignal.2004652.
pmc_ranked_result_index: '9210'
pathway_score: 0.9598509
filename: nihms-549624-f0001.jpg
figtitle: Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in
  Lung Cancer
year: ''
organisms: Homo sapiens
ndex: a054e53e-ded5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3876281__nihms-549624-f0001.html
  '@type': Dataset
  description: In drug-sensitive cancers (left), the mutant oncogene exerts unilateral
    control over RAS, MEK/ERK, and PI3K/AKT pathway signaling. When inhibited by the
    appropriate TKI, these pathways are suppressed, resulting in cell cycle arrest
    and apoptosis. In drug-resistant cancers with a bypass track (right), the secondary
    RTK reactivates the signaling of at least one of the key downstream pathways,
    whereas the primary oncogene remains inhibited. Sustained activation of these
    pathways leads to continued cell proliferation and survival in the presence of
    TKI.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAF1
  - PIK3CD
  - PIK3CB
  - MAP2K1
  - AKT1
  - PIK3R3
  - PIK3CA
  - PIK3CG
  - PIK3R4
  - MAPK3
  - AKT3
  - ARAF
  - PIK3R5
  - PIK3R6
  - MAPK1
  - CRTC1
  - HRAS
  - MAP2K2
  - EGFR
  - NRAS
  - KRAS
  - AKT2
  - BRAF
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TORC1
  symbol: TORC1
  source: hgnc_alias_symbol
  hgnc_symbol: CRTC1
  entrez: '23373'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: EGFR,EML4-ALK
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3876281__F1
redirect_from: /figures/PMC3876281__F1
figtype: Figure
---
